Clinical Trial Update: Evaluate the Efficacy and Safety of Fasinumab in Patients With Moderate-to-Severe Chronic Low Back Pain and Osteoarthritis of the Hip or Knee [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating fasinumab for chronic low back pain and osteoarthritis; terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Back Pain
• Osteoarthritis

Drugs mentioned

• Fasinumab (fasinumab)

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Chronic Low Back Pain, Osteoarthritis | Phase 3 | Status: TERMINATED | Results posted: 2021-06-30